The Patent Finder

Maintenance fees coming due

Biosplice Therapeutics, Inc.

36 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Dec 6, 2026. Unpaid by Jun 7, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,667,6322-(1H-Indazol-3-yl)-3H-imidazo[4,5-c]pyridines and Their Anti-Inflammatory Uses Thereof
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 6, 2026Jun 7, 2027High confidence
US 10,314,832B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 11, 2026Jun 11, 2027High confidence
US 11,673,881ISOQUINOLIN-3-YL Carboxamides and Preparation and Use Thereof
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 13, 2026Jun 14, 2027High confidence
US 11,673,885Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 13, 2026Jun 14, 2027High confidence
US 10,329,3093-(3H-Imidazo[4,5-b]pyridin-2-yl)-1H-pyrazolo[4,3-b] Pyridines and Therapeutic Uses Thereof
In force
Fee due Dec 25, 2026
Lapses if unpaid Jun 25, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 25, 2026Jun 25, 2027High confidence
US 11,684,615Methods of Using INDAZOLE-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 27, 2026Jun 28, 2027High confidence
US 9,067,9391H-Pyrazolo[3,4-b]pyridines and Therapeutic Uses Thereof
In force
Fee due Dec 30, 2026
Lapses if unpaid Jun 30, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceDec 30, 2026Jun 30, 2027High confidence
US 10,342,7881H-Pyrazolo[3,4-b]pyridines and Therapeutic Uses Thereof
In force
Fee due Jan 9, 2027
Lapses if unpaid Jul 9, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceJan 9, 2027Jul 9, 2027High confidence
US 10,350,1993-(1H-Pyrrolo[2,3-b]pyridin-2-yl)-1H-indazoles and Therapeutic Uses Thereof
In force
Fee due Jan 16, 2027
Lapses if unpaid Jul 16, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceJan 16, 2027Jul 16, 2027High confidence
US 9,090,613Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof
In force
Fee due Jan 28, 2027
Lapses if unpaid Jul 28, 2027
 · High confidence
Biosplice Therapeutics, Inc.In forceJan 28, 2027Jul 28, 2027High confidence
26 more maintenance fees coming due in the 12 months from Nov 17, 2026 · Pro
10 of 36 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited